These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29853702)

  • 1. [Ethical and legal problems arising from off-label use of medical devices and some solution recommendations].
    Ekmekçi PE; Arda B
    Turk Kardiyol Dern Ars; 2018 Jun; 46(4):318-325. PubMed ID: 29853702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No. 121.
    Thomadsen BR; Heaton HT; Jani SK; Masten JP; Napolitano ME; Ouhib Z; Reft CS; Rivard MJ; Robin TT; Subramanian M; Suleiman OH
    Med Phys; 2010 May; 37(5):2300-11. PubMed ID: 20527564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-Label Use of Medical Devices in Children.
    ;
    Pediatrics; 2017 Jan; 139(1):. PubMed ID: 28025239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for sarcoidosis: an example of an off-label procedure.
    Zimmermann A; Dubaniewicz A; Slominski JM
    Adv Exp Med Biol; 2013; 755():251-6. PubMed ID: 22826074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioethics committees and examining consent within the patient-physician relationship in Turkey.
    Büken NO; Arapkirlioglu K
    Med Law; 2010 Sep; 29(3):403-18. PubMed ID: 22145560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical Off-label Drug use: Need for a Rethink?
    Zheng Z; Yang M; Wu J
    Indian Pediatr; 2017 Jun; 54(6):447-450. PubMed ID: 28667712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics of medical device safety.
    Kriewall TJ
    J Long Term Eff Med Implants; 2008; 18(2):167-74. PubMed ID: 19968625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications.
    Zhang MW; Harris KM; Ho RC
    BMC Med Ethics; 2016 Jan; 17():4. PubMed ID: 26768892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Telecommunications, health and radiology: potential synergies for the new millennium].
    Lagalla R
    Radiol Med; 2001; 102(1-2):14-9. PubMed ID: 11677432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical dilemmas in hyperbaric medicine.
    Chan EC; Brody B
    Undersea Hyperb Med; 2001; 28(3):123-30. PubMed ID: 12067147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in off-label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies.
    França K; Litewka S
    Int J Dermatol; 2019 Jul; 58(7):788-794. PubMed ID: 30168846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical governance of the medical research: clinical investigation and informed consent under the new EU Medical Devices Regulation (2017∕745).
    Olimid DA; Olimid AP; Ifrim Chen F
    Rom J Morphol Embryol; 2018; 59(4):1305-1310. PubMed ID: 30845317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of medicines: The need for good practice guidelines.
    Dooms M; Killick J
    Int J Risk Saf Med; 2017; 29(1-2):17-23. PubMed ID: 28885218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities.
    Van Norman GA
    JACC Basic Transl Sci; 2023 Feb; 8(2):224-233. PubMed ID: 36908673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing "Off-Label": What Should a Physician Disclose?
    Furey K; Wilkins K
    AMA J Ethics; 2016 Jun; 18(6):587-93. PubMed ID: 27322992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence or no alternative? Taking responsibility for off-label prescribing.
    Ghinea N; Lipworth W; Kerridge I; Day R
    Intern Med J; 2012 Mar; 42(3):247-51. PubMed ID: 22432984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A step-by-step guide for safe off-label prescribing].
    van der Zanden TM; Schrier L; de Wildt SN
    Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label and unlicensed prescribing in Europe: implications for patients' informed consent and liability.
    Aagaard L; Kristensen K
    Int J Clin Pharm; 2018 Jun; 40(3):509-512. PubMed ID: 29721740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.